What is Dreamax?
Dreamax Incorporated, alongside its affiliate Dreamax Lifesciences Corporation, operates as a key importer of pharmaceuticals, medical devices, nutraceuticals, and cosmetics in the Philippines. As a venture of the AMICO Group of Companies, Dreamax is committed to enhancing its product lines, market reach, and overall portfolio. The company focuses on delivering high-quality, reasonably-priced items to its network of distributors, hospitals, and consumers, aiming to solidify its position in the healthcare and wellness sectors.
How much funding has Dreamax raised?
Dreamax has raised a total of $37K across 1 funding round:
Debt
$37K
Debt (2021): $37K with participation from PPP
Key Investors in Dreamax
PPP
Public-Private Partnership
What's next for Dreamax?
The recent influx of substantial expansion capital at a significant Series B/C stage suggests Dreamax is poised for accelerated growth and market penetration. This financing is likely to fuel strategic initiatives such as broadening its product offerings, expanding its distribution network across the Philippines, and potentially exploring new market segments. The company's focus on quality and affordability, coupled with its backing from the AMICO Group, positions it for sustained development and increased market share in the competitive healthcare import industry.
See full Dreamax company page
